NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Aster DM Healthcare Limited Financial Update

On March 26, 2026, the Board of Directors of Aster DM Healthcare Limited will convene to consider and approve the declaration of an interim dividend for the financial year 2025-26. The record date for determining eligible shareholders has been set as April 3, 2026.

Trading Window Closure In line with insider trading norms, the trading window for Aster DM Healthcare Limited has been closed from March 19, 2026, and will remain shut until 48 hours after the announcement of the company's financial results for the quarter and year ended March 31, 2026.

Stock Performance Despite a broader market rally on March 20, 2026, Aster DM Healthcare Limited stock fell by 1.2% to its day's low of ₹628.70. This marks the third consecutive session of loss for the healthcare stock, with a combined decline of over 6% in these three sessions. However, the stock has been flat but positive in the last one month and has added around 6% in the past three months.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Recent Financial Results For the quarter ended December 31, 2025, Aster DM Healthcare Limited reported a net profit of ₹52.45 crore, a decline of 7.64% from the same period last year. Revenue from operations rose by 12.9% year-on-year to ₹1,185.7 crore, while EBITDA stood at ₹211 crore, reflecting a 2.5% increase from the previous year. EBITDA margin eased slightly to 17.8% from 18%.

Impact of Labour Code Implementation The company's Q3 profitability was impacted by one-time charges arising from the implementation of new Labour Codes notified on November 21, 2025. The impact included ₹26.27 crore towards gratuity and ₹1.59 crore related to compensated absences, largely due to revised wage structures. The company continues to monitor the finalisation of Central and State-level rules and is awaiting further clarity from the government.

Investor Takeaway

Investors should monitor the upcoming board meeting for potential dividend declaration.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.